Deadly Wuhan Coronavirus



Massive UK Moderna partnership​

UK cements 10-year-partnership with Moderna in major boost for vaccines and research

Moderna to invest in mRNA research and development (R&D) in the UK,

and build a state-of-the-art vaccine manufacturing centre,

with the ability to produce up to 250 million vaccines a year

Suggested advantages

NHS patients will have access to a UK-made supply of COVID-19 jabs,

as well as cutting-edge vaccines developed for other respiratory diseases,

such as flu and respiratory syncytial virus (RSV)

Create more than 150 jobs

Further future-proof the UK against potential pandemics,

speedy access to the latest advancements in vaccine technology

UK cements its status as a life sciences superpower.

The partnership with Moderna

UK Health Security Agency (UKHSA) working with Moderna,

to ensure early vaccine development,

supporting the G7 mission to get from variant to vaccine in 100 days.

NHS patients access to Moderna’s COVID-19 vaccines,

that can protect against multiple variants.

This is the finalization of the partnership,
led by the Vaccine Task force.

Secretary of State for Health and Social Care, Steve Barclay

It is vital we invest in fighting future variants of this disease, (covid),

as well as other deadly viruses that are circulating,

such as seasonal flu and RSV,

and this partnership with Moderna will also strengthen our ability to respond to any future pandemics.

We are also told

Moderna worked closely with the Vaccine Task Force during the pandemic,

The company has now committed to invest substantial funding in UK-based research and development activities,

over a 10-year period.

Perhaps, most concerning of all

his will include running a significant number of clinical trials in the UK

and it has also pledged to fund grants for UK universities,

including PhD places and research programmes.

Not mentioned in press release

Full explanation as to why the focus is exclusively on mRNA vaccines, rather than tired and tested traditional vaccines.

Why the UK government needs Moderna?

The partnership will issue guarantees that the funding will in no way influence the agenda of the employed scientists.

A graduate student will be awarded his or her PhD, based purely on the quality of the research.

There will be no sanction of scientists that offer alternative views to the prevailing narrative.

Scientists will not be threatened or cajoled in any way.

Within reason, scientists will be able to choose what they want to research, not be ordered into proving a desired concept.

Science will not be used to provide evidence for a development that looks profitable.

Science and medicine will never be subjugated to commercial interests.

There will be independent oversight of the partnership.

If promising none mRNA vaccine looks interesting this will not squashed.

Extensive studies will be carried out on systemic distribution of the mRNA

All organs will be examined for damage caused by systemic distribution of mRNA

Brain, heart, lungs, liver, kidneys, spleen.

Adverse effects on physiological systems will be closely monitored
All results will be published, whether negative or positive.

There will be no publication bias, (where favourable results are published and publicized, while less favourable results are squashed).

Research reports will not be ghost written by Moderna or representatives of the partnership.

The peer review process will have guaranteed anonymity, i.e. will be blind.

Full, anonymised source data will be in the public domain for independent analysis.

All adverse events will be published in full, combined with all relevant psychophysiological data, blood results, clinical examinations, investigation results, histology.

All recruits to clinical trials will receive full information disclosure, so they can give full informed consent before agreeing to be a trial participant.

Full accounts, including commercial profits will be placed into the public domain, at least every year.

Studies on intramuscular injection technique to prevent systemic administration.


Construction is expected to commence in early 2023,

with the first mRNA vaccine expected to be produced in the UK in 2025.

Dr Jenny Harries, Chief Executive of UKHSA
I’m delighted that…

Stéphane Bancel, Chief Executive Officer of Moderna
Our new state-of-the-art facility will bring mRNA manufacturing to UK shores,
Ect. Ect.


the details of the strategic partnership between the government and Moderna are commercially sensitive

That last sentence means they can keep secrets without accountability.


As Above So Below

Mike Pompeo demands US BANS Chinese travelers after Beijing eased travel restrictions -and claims Xi Jinping is trying to infect the world with another variant of COVID

Former Secretary of State Mike Pompeo insists the U.S. - and the world - should shut down accepting travel from China right after the Communist country announced it would be easing travel restrictions in the New Year. He warned that Chinese President Xi Jinping has a plot to infect the world and spread a new COVID-19 variant after 'the whole world has been through hell.' China, which has the most stringent COVID-19 restrictions still in place, announced last month that it would start allowing travel out of and into the country following three years of 'zero COVID' policies.



It would behoove you to keep in mind that the USA, Canada, Australia, and the United Kingdom have all partnered with Moderna to build vaccine factories and they are committed to buying the product for the next 10 years.

Full video first posted 24th December 2022.

Moderna Chief Executive Stephane Bancel

That capacity that we’re building in the UK, that they are committed to buying the product for the next ten years


the details of the strategic partnership between the government and Moderna are commercially sensitive

UK, Prime Minister, Moderna (2020)

Mr. Sunak refused to disclose whether he will profit from a surge in the share price of Moderna Theleme has a $500m investment in US-based Moderna

Mr. Sunak was a founding partner of Theleme Partners and one of the executives managing its US office. He left the firm in 2013 Theleme is registered in the Cayman Islands (which does not make company records public) Moderna goes global


New factory in Montreal area, Laval, Que Mr. Trudeau took part in a groundbreaking ceremony Completed in 2024 or 2025 mRNA vaccines, 100 million doses per year Covid, influenza, respiratory syncytial virus Innovation

Minister François-Philippe Champagne Canada committed to purchase a certain number of vaccines

Part of a seven-year agreement

200+ workforce

No to leave out Australia

Monash Technology Precinct, Victoria COVID-19, influenza and respiratory syncytial virus (RSV)

100 million doses per year mRNA vaccines

Monash Vice-Chancellor, Professor Margaret Gardner bring together all of the elements of an mRNA innovation ecosystem that will deliver long-term health and economic benefits for the community


This is 1:08 minutes long. Is that a lot for me to ask of your time? NO! Normally, I would say, yes. Get the picture?

Please, I'm begging you, take the time, make some popcorn and sit down to watch this. We seem to have such short memories because so much new stuff is thrown at us everyday by the internet and news outlets that it keeps us moving on to new stories and we forget that the one we were previously involved in is not over...



As Above So Below

China admits its Covid deaths are 'huge' and 70% of Shanghai's 25m residents have been infected as Beijing threatens retaliation against Western nations over restrictions on air passengers

The steep rise in infections came after years of Beijing's 'zero-Covid' hardline approach was abruptly loosened last month with little warning or preparation, and quickly overwhelmed hospitals and crematoriums. In a rare admission, health officials said on Chinese television that the country was seeing an increase 'in the critical cases or the fatalities', but also attempted to play down the situation by saying the surge was - for a nation with the world's largest population - in line with other countries. Despite the admission, Beijing also condemned fresh Covid test requirements by around a dozen countries on passengers travelling abroad from its territory, warning on Tuesday it could take 'countermeasures' in response. Pictured: Scenes from inside hospitals in China which are quickly being overwhelmed with Covid patients.



As Above So Below
It already says the page does not exist.

You're ad blocking perhaps is set too high then, click the link and see that its active to Twitter...



As Above So Below
The late Nobel Prize Winner Dr. Kary Mullis, the inventor of the PCR test, had been blowing the whistle on Fauci and big pharma for thirty years. He CONVENIENTLY died in august of 2019. Some might be interested in hearing what he thought of doc Fauci.




As Above So Below

'We can't do this EVERY winter': Fury over Government plans to bring back Covid-era measures to avoid full-blown NHS meltdown - as zealots demand masks in public, WFH by default and return of social distancing

Ministers are said to be considering issuing fresh guidance to wear masks on public transport, work-from-home and socially distance if pressure on the health service continues to rise. Hospital bosses have already warned the crisis will continue to Easter. Some experts have advised that Britons should already start limiting their contacts and not going into the office to limit the spread of winter viruses. The NHS is facing record winter pressures due to rising rates of Covid and flu, staff shortages and too few beds, while experts fear an Omicron sub-variant will drive a surge in infections, piling even more pressure on the already-crippled health service. Health chiefs and scientists have already advised the adults and pupils to stay at home if they are unwell, don masks if they must go outside when sick and called for the booster rollout to be widened in a bid to ease NHS demand.




Factors in infection risk​


The risk of COVID-19 also varied by the number of COVID-19 vaccine doses previously received. The higher the number of vaccines previously received, the higher the risk of covid infection.

Download free high-res PDFs of the posters, download free copies of my two text books. Any donations using this link help the work of campbell teaching.

Order a hard copy Physiology book in the UK,

Vaccine doses versus risk of covid during the 3-month study period

One dose, 1.7 times more likely to test positive for covid

Two doses, 2.63 times more likely to test positive for covid

Three doses, 3.1 times more likely to test positive for covid

More than three doses, 3.8 times more likely to test positive for covid

So compared to the unvaccinated

1, x 1.7

2, x 2.36

3, x 3.1

4, x 3.38

P = 0.001 means 999 out of 1,000 likely to be a genuine result

That 99.9% likely to be a genuine result

Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine

In 2020

(published in 2021) Evidence that vaccines prevented covid infection

This was when the human population had just encountered the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus

Things Have Changed (Dylan)

Bivalent antigens

Original vaccine and BA.4/BA.5 lineages of Omicron.

(Approved without demonstration of effectiveness in human clinical studies)

(Approved without demonstration of safety in human clinical studies)

Background To evaluate whether a bivalent COVID-19 vaccine protects against COVID-19.


Employees of Cleveland Clinic, n = 51,011

Cumulative incidence of COVID-19 was examined over the following weeks.

Protection provided by recent and prior vaccination was evaluated

First bivalents given, 12 September 2022

Three-month study


Among 51,011 employees, 20,689 (41%) had had a previous documented episode of COVID-19,

42,064 (83%) had received at least two doses of a vaccine.

10,804 (21%) were bivalent vaccine boosted

COVID-19 occurred in 2,452 (5%) during the study.

(Pfizer 89%, Moderna 11%)

Risk of COVID-19 increased with time since the most recent prior COVID-19 episode

Risk of COVID-19 increased with the number of vaccine doses previously received.

Note, this is based on large numbers

Doses, 0 = 6,419 (12.6%)

Doses, 1 = 2,528 (5%)

Doses, 2 = 14,810 (45.9%)

Doses, 3 = 23,396 (45.9%)

Doses 4, 3,757 (7.4%)

Doses 5, 85 (less than1%)

Doses 6, 16 (less than 1%)

The bivalent vaccinated state Was independently associated with lower risk of COVID-19 (HR, 0.70)

(over the 3 months of the study)

Leading to an estimated vaccine effectiveness (VE) of 30%

CDCs latest variant data

Things Have Changed (Dylan)


As Above So Below
Cough (Cover-up!)...


Health Care Workers Cry Foul on FDA Claiming It Didn’t Prohibit Ivermectin for COVID-19

Dr. Yusuf Saleeby has practiced medicine for more than 30 years. He serves patients in South Carolina and until recently had never faced an investigation from his state medical board. But after Saleeby started prescribing ivermectin to his patients, he was reported to the board, which opened an investigation, despite the state’s attorney general’s promise that his office wouldn’t prosecute doctors who prescribed off-label medications.

Jennifer Wright, a nurse practitioner and clinical director who practices in Florida, but can prescribe across state lines, told The Epoch Times she received a letter from the Office of the Attorney General of New York ordering her not to prescribe ivermectin. “You know, basically threatened me. If I don’t stop prescribing, then they’re going to fine me,” Wright said about the letter, which threatened legal action with fines of up to $5,000 per violation.

The letter stated that the Food and Drug Administration only authorized ivermectin for use in humans when treating “parasitic worms and head lice and skin conditions like rosacea.” The citation in the letter appears to be from an FDA advisory issued in March 2021 titled “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19.”

That advisory and other anti-ivermectin messaging from the FDA are now the subject of a lawsuit brought by three doctors against the agency. The doctors argue that the FDA illegally interfered with their ability to treat patients. The suit was dismissed but an appeal has been filed by the plaintiffs.

During a hearing in 2022, attorneys defending the government argued that the agency’s missives were just a recommendation. “They did not say it’s prohibited or it’s unlawful. They also did not say that doctors may not prescribe ivermectin,” Isaac Belfer, one of the lawyers for the government, said during a Nov. 1, 2022, hearing in federal court in Texas.

The government’s arguments differ greatly from the reality many doctors faced for prescribing ivermectin. Some lost their jobs, others were investigated by state medical boards, and many received threats from the New York attorney general because they were prescribing across state lines.

Matthew Dark, a spokesperson for Roots Medical and Colorado Healthcare Providers for Freedom, which has more than 275 physicians in the group, stated that several doctors in Colorado are facing investigations by the state medical board. When asked about the FDA’s new claim, Dark stated: “They knew it was safe for humans, and they made that very accusatory thing if you were a doctor prescribing this, you were an idiot. You were practicing like a hillbilly. So that message was loud and clear.”

Dark referred to Twitter posts from the FDA, one of which said: “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”

“Pharmacies were responding to the practice and providers trying to write [ivermectin] the same way the FDA was behaving,” Dark said.

Wright concurred, and pointing to her letter from the New York attorney general, said, “It clearly states in this letter that according to the FDA, you must cease and desist in prescribing ivermectin to New York State residents.”

(More on the link)